Randomized, Double-Blind, Placebo-Controlled Evaluation of the Tolerability of Two Civamide (Zucapsaicin) Patch Strengths Compared to Placebo Patch in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2011
At a glance
- Drugs Zucapsaicin (Primary)
- Indications Pain; Postherpetic neuralgia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Winston Laboratories
- 10 Feb 2009 Status changed from active, no longer recruiting to completed as reported by Winston Pharmaceuticals.
- 10 Feb 2009 Positive top-line results reported by Winston Pharmaceuticals.
- 05 Jan 2009 Planned end date changed from 1 Nov 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.